Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative Diseases-Reference-Cited by-同舟云学术

Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative Diseases

Published:2021-11-02 Issue:22 Volume:12 Page:4302-4318
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Aboushady Youssef¹,Gabr Moustafa²,ElHady Ahmed K.¹³^ORCID,Salah Mohamed⁴,Abadi Ashraf H.¹^ORCID,Wilms Gerrit⁵,Becker Walter⁵,Abdel-Halim Mohammad¹^ORCID,Engel Matthias⁶^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt

2. Department of Radiology, Stanford University, Stanford, California 94305, United States

3. School of Life and Medical Sciences, University of Hertfordshire Hosted By Global Academic Foundation, New Administrative Capital, Cairo 11311, Egypt

4. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, October University for Modern Sciences and Arts, Cairo 12451, Egypt

5. Institute of Pharmacology and Toxicology, Medical Faculty of the RWTH Aachen University, Wendlingweg 2, Aachen 52074, Germany

6. Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C2.3 Saarbrücken D-66123, Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.1c00475

Reference85 articles.

1. Dyrk, a Dual Specificity Protein Kinase with Unique Structural Features Whose Activity Is Dependent on Tyrosine Residues between Subdomains VII and VIII

2. DYRK protein kinases

3. Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region

4. DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications

5. Link Between DYRK1A Overexpression and Several-Fold Enhancement of Neurofibrillary Degeneration With 3-Repeat Tau Protein in Down Syndrome

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual targeting of inflammation and β-cell dysfunction for therapy of diabetes mellitus;Journal of Drug Delivery Science and Technology;2024-08

2. Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity;European Journal of Medicinal Chemistry;2024-04

3. Function and inhibition of DYRK1A: Emerging roles of treating multiple human diseases;Biochemical Pharmacology;2023-06

4. Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-02-15

5. Oligomeropathies, inflammation and prion protein binding;Frontiers in Neuroscience;2022-08-23